surgical 
                  pearls
Managing Floppy Iris 
                  Syndrome
Use of 
                  Flomax has been tied to this complication.
By 
                  Jerry Helzner, Senior Editor
                  
David F. Chang, M.D., and John R. 
                  Campbell, M.D., have recently identified a new small-pupil 
                  syndrome they've named Intraoperative Floppy Iris Syndrome 
                  (IFIS). They've tied it to use of Flomax, the most commonly 
                  prescribed alpha-adrenergic blocker for the treatment of 
                  benign prostatic hypertrophy (BPH).
                  
IFIS during cataract surgery is 
                  characterized by: iris billowing in response to normal 
                  irrigating fluid currents; a strong tendency toward iris 
                  prolapse; and progressive miosis during the phaco and cortical 
                  irrigation/aspiration (I/A) steps.
                  
In this article, we'll provide 
                  several pearls that surgeons should consider when confronted 
                  with a potential IFIS case. 
                  
                  
                    
                    
                      | 
 |  | 
                    
                      | IFIS is 
                        characterized by iris billowing, prolapse to phaco and 
                        side port incisions, and progressive miosis during 
                        phaco.
 |  | 
 
                  Mitigating IFIS
                  
Dr. Chang offers the following 
                  surgical pearls for preventing or mitigating IFIS:
                  
"If the pupil dilates poorly 
                  preoperatively, you should specifically ask about prior Flomax 
                  use. Even if it has been stopped for 1 to 2 years, IFIS can 
                  still occur, indicating that there must be some permanent 
                  change to the iris dilator muscle. Some urologists prescribe 
                  Flomax for urinary retention symptoms in women, and 
                  predictably, IFIS has been encountered in female Flomax 
                  patients.
                  
"It is not clear whether other 
                  nonsubtype-specific alpha-1 blockers cause IFIS. While the 
                  IFIS patients in our two studies were all on Flomax, a few 
                  anecdotal reports note IFIS in patients on Hytrin, Cardura, 
                  and Uroxatrol.
                  
"Several features of IFIS increase 
                  the risk of complications for an unsuspecting and uninformed 
                  surgeon. First, if the pupil is small, commonly used 
                  mechanical stretching techniques, with or without partial 
                  thickness sphincterotomies, are ineffective in maintaining an 
                  adequate pupil diameter. Furthermore, some IFIS pupils dilate 
                  quite well, or expand well enough following viscoelastic 
                  injection to make the capsulorhexis step quite 
                  straightforward. It is not until hydrodissection and phaco 
                  that the problems of IFIS suddenly and unexpectedly 
                  occur.
                  
"We reported increased 
                  retrospective posterior capsule rupture rates with IFIS, and 
                  believe that the unanticipated cascade of iris misbehavior was 
                  the likely explanation.
                  
"A number of different approaches 
                  have been tried with varying success. Stopping the Flomax for 
                  1 to 2 weeks seems to permit wider dilation in some eyes, but 
                  doesn't alone prevent IFIS. 
                  
"Dr. Sam Masket feels that stronger 
                  cycloplegia, such as with atropine, may help. Dr. Dick 
                  Lindstrom feels that supracapsular phaco is a helpful 
                  technique, wherein the prolapsed and tilted nucleus keeps the 
                  pupil from constricting all the way down. Drs. Bob Osher and 
                  Doug Koch rely on Healon5 (see below). "I have found that the 
                  tighter 1.2-mm incisions of bimanual microincisional phaco are 
                  of some help in preventing iris prolapse.
                  
"I believe that all of these 
                  strategies work much better if the iris dilates reasonably 
                  well to begin with, and are less effective if the pupil is 
                  already small. In that case, the best strategy is to employ 
                  iris retractors in a diamond configuration as described by Dr. 
                  Tom Oetting. Although this increases the cost and surgical 
                  time, it assures a safe-sized pupil opening throughout the 
                  case. Pupil expansion rings are another option, but can be 
                  more difficult to insert if the chamber is shallow, or the 
                  pupil is small."
                  
Using Healon5
                  
To safely and effectively manage 
                  the challenges of IFIS, Robert H. Osher, M.D., uses his 
                  slow-motion phaco technique and Healon5.
                  
In slow-motion phaco, vacuum, 
                  aspiration and infusion are carefully managed. After an 
                  initial vacuum of 250 mmHg to burrow into the lens, vacuum and 
                  aspiration rates are kept lower than normal, which allows a 
                  lower infusion rate and fosters stability.
                  
The viscosity and space occupation 
                  properties of Healon5 make it ideal for use with this 
                  technique, Dr. Osher says. 
                  
"First, viscomydriasis with Healon5 
                  allows me to create an adequate capsulorhexis without iris 
                  prolapsing to the wound," he explains.
                  
"During nucleus chopping and 
                  removal, not only does the slow-motion phaco preserve the 
                  Healon5 in the anterior chamber, it deters the floppy iris 
                  from 'leaping' into the phaco tip, even though the pupil may 
                  get smaller. I have also learned how to remove cortex without 
                  disturbing the OVD, still keeping the floppy iris from 
                  leaping."
                  
                  
                    
                    
                      | 
 |  | 
                    
                      | Disposable 
                        iris retractors placed in a diamond configuration in 
                        IFIS patient. Subincisional retractor is placed through 
                        a separate stab incision just posterior to the phaco 
                        incision.
 |  | 
 
                  For removal of the Healon5, Dr. 
                  Osher places the I/A tip under the IOL, directs the port 
                  toward the single-piece acrylic IOL, and with several seconds 
                  of high vacuum, evacuates the viscoelastic from the capsular 
                  bag. To complete the evacuation, he places the tip in the 
                  anterior chamber with the port toward the cornea.
                  
Before he removes the irrigating 
                  tip, he puts the 27-gauge cannula through the stab incision 
                  and holds it against the optic. He injects Miochol as the I/A 
                  tip is being withdrawn.
                  
"This maneuver keeps the chamber 
                  from abruptly shallowing because the Healon5 effectively masks 
                  positive pressure," Dr. Osher says. "The iris prolapse is 
                  retarded by the deeper chamber into which the pupil rapidly 
                  constricts from the Miochol."
                  
Dr. Osher has performed 
                  phacoemulsification on approximately a dozen patients with 
                  IFIS, and says, "I have not had to rely on either iris hooks 
                  or a mechanical device for pupil dilation." 
                  
Multicenter Study 
                  Started
                  
"We don't really know whether IFIS 
                  will be associated with a higher rate of cataract surgical 
                  complications now that ophthalmologists can foresee and 
                  anticipate the problem," says Dr Chang. "For this reason, 
                  we've started a multicenter prospective study to assess what 
                  the complication rate of IFIS will be, as long as the surgeon 
                  is prepared and able to use alternative pupil management 
                  strategies such as those we describe. We plan to enroll up to 
                  150 consecutive Flomax patients at 11 sites across the 
                  country."